Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Foundations

What Are Research Peptides? A Clear Educational Guide

Learn what “research peptides” means, how they differ from approved peptide drugs, quality markers (COA, purity), and how to study them responsibly.

By The Peptides Codex Editorial TeamIndividual review date not recorded

Definition

“Research peptides” is a market and laboratory term for synthetic peptides intended for in vitro or animal experimental work—not for diagnosis, cure, mitigation, or treatment of disease. The phrase is descriptive of intent and quality systems, not a legal free pass. Approved peptide medicines (insulin, semaglutide, octreotide, etc.) are a different regulatory category with clinical trials, manufacturing standards, and labeled indications.

Research peptides vs therapeutic peptides

Therapeutic peptides are authorized drugs. They have defined purity specifications, sterile manufacturing where required, stability data, and prescribing information. Research materials may be sold as lyophilized powders with a certificate of analysis (COA) stating HPLC purity and identity by mass spectrometry—but they are typically not produced under pharmaceutical GMP for human injection, and labeling “for research use only” does not convert them into medicines.

Separate a molecule from a marketing claim

A compound name identifies a subject for investigation; it does not establish recovery, cosmetic or longevity benefits. Begin with molecular identity, then check what was measured, in which model or population, and by which exposure route. Keep a studied medicine, a laboratory reagent and a marketed blend distinct.

Quality signals that matter in the lab

For laboratory procurement discussions, look for: batch-specific COA, HPLC chromatogram, mass spectrum consistent with theoretical mass, stated net peptide content, residual solvent and TFA notes, and storage guidance. “99% pure” without a method or batch ID is not meaningful analytical science.

Regulatory literacy (high level)

Rules differ by country. In Canada and many other markets, peptides marketed for human injection without authorization are generally treated as unapproved drugs. Advertising disease treatment claims to the public can be separately illegal. This guide is educational and is not legal advice—consult qualified counsel for commercial activities.

How to use this site

Start with individual peptide profiles for sequence and research context, use the sequence playground for biophysical intuition, and read comparison guides when evaluating related compounds. When a research catalog is linked, treat it as a product specification source—not medical guidance.

Sources and what they cover

These primary studies, official records and standards cover the topics linked below. The scope notes distinguish laboratory findings, human trials and regulatory records. This is a selected bibliography, not a systematic review or verification of every sentence; absence of a study here does not prove that no study exists.

  1. IUPAC Gold Book — peptides

    Chemical terminology; no evidence of treatment effectiveness.

    Relevant sections: Definition · Research peptides vs therapeutic peptides

  2. Health Canada (2026) — unauthorized injectable peptides bought online

    Canadian safety and authorization notice for the products described. It does not establish approval status in every country.

    Relevant sections: Research peptides vs therapeutic peptides · Regulatory literacy (high level)

  3. ICH Q2(R2) — Validation of Analytical Procedures (FDA guidance)

    Analytical validation framework. A chromatogram alone does not validate identity, content, sterility or fitness for human use.

    Relevant sections: Quality signals that matter in the lab

FAQ

Are research peptides legal?+

It depends on jurisdiction, product form, marketing claims, and intended use. Laboratory research materials and human therapeutics are regulated differently. “Research use only” labeling does not automatically legalize sale for human consumption.

Are research peptides the same as steroids?+

No. Most popular research peptides are not anabolic steroids and are usually outside classic controlled-substance steroid schedules—but they can still be regulated as drugs under food and drug law.

What does RUO mean?+

Research Use Only indicates the supplier’s stated intended use is laboratory research, not clinical care. It is not a guarantee of legality or safety for human use.

Related peptide profiles

BPC-157
Research pentadecapeptide (gastric-juice-derived sequence)
BPC-157 (Body Protection Compound-157) is a synthetic 15-residue peptide, GEPPPGKPADDAGLV, derived from a sequence found in human gastric juice. Hundreds of rodent studies, most from a single Zagreb group, report accelerated healing of tendon, muscle, ligament, gut and skin injuries via VEGFR2, nitric-oxide and ERK1/2 pathways. Human evidence is limited to a small safety study and a retrospective chart review; the first phase 2 efficacy trial began recruiting in 2026. It is not approved anywhere and the FDA barred it from compounding in 2023.
TB-500
Synthetic thymosin β4 fragment (research peptide)
TB-500 is the synthetic, N-acetylated heptapeptide Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ), corresponding to residues 17–23 of thymosin β4, the protein's actin-binding motif. It first appeared as a veterinary preparation and is sold as a research chemical; its metabolism has been characterised in rats. A 2026 rat tendon study reported benefits with vendor-labelled TB-500 whose sequence was not characterized, so it does not establish efficacy of Ac-LKKTETQ. The fragment has no published human efficacy data. No product-specific authorization record has been verified in this profile; human trial registration does not establish approval. Its first registered human trial began recruiting in 2026.
CJC-1295
Long-acting GHRH analogue (research compound)
CJC-1295 (C165H269N47O46, ≈3,647 Da) is a 30-residue analogue of growth hormone-releasing hormone(1-29) engineered by ConjuChem to bind serum albumin covalently after injection, extending its action from minutes to days. In healthy adults a single injection raised growth hormone 2- to 10-fold for six days or more and IGF-1 1.5- to 3-fold for 9–11 days, with an estimated half-life of 5.8–8.1 days. It was never approved: a phase 2 trial in HIV-associated visceral obesity was terminated, and it is now an unapproved research peptide prohibited in sport.
Ipamorelin
Growth hormone secretagogue (research compound)
Ipamorelin (NNC 26-0161) is a synthetic pentapeptide — Aib-His-D-2-Nal-D-Phe-Lys-NH2 (C38H49N9O5, ≈712 Da) — developed by Novo Nordisk as the first growth hormone secretagogue that released growth hormone without stimulating ACTH or cortisol. It acts at the ghrelin receptor. It has never been approved: phase 2 trials in post-operative ileus were completed without a filing, and it is sold today as an unapproved research peptide and prohibited in sport.
Semaglutide
Incretin analog
Semaglutide is a 31-amino-acid GLP-1 receptor agonist peptide (C187H291N45O59, ≈4,114 Da). It keeps 94% of the human GLP-1 sequence but substitutes Aib at position 8 to block DPP-4 cleavage, replaces Lys34 with Arg, and attaches a C18 fatty diacid to Lys26 through a γ-glutamate and two OEG spacers so the peptide binds albumin. The result is a half-life of about 7 days and once-weekly dosing in the approved products Ozempic and Wegovy (and once-daily oral dosing as Rybelsus).

More guides

Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Regulations vary by jurisdiction.
You might also like: All guides · Encyclopedia · Tools · FAQ
Cite this: Peptides Codex — What Are Research Peptides? A Clear Educational Guide
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.